Your search returned 122 results.

Results
	41.	What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 days. [electronic resource] by van der Gaast, A Vlastuin, M Kok, T C Splinter, T A Producer: 19930222 In: Seminars in oncology vol. 19 Availability: No items available. Save to lists Add to cart (remove)
	42.	Intrathecal administration of etoposide in the treatment of malignant meningitis: feasibility and pharmacokinetic data. [electronic resource] by van der Gaast, A Sonneveld, P Mans, D R Splinter, T A Producer: 19920330 In: Cancer chemotherapy and pharmacology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	Absolute bioavailability and pharmacokinetics of oral teniposide. [electronic resource] by Splinter, T A Holthuis, J J Kok, T C Post, M H Producer: 19921026 In: Seminars in oncology vol. 19 Availability: No items available. Save to lists Add to cart (remove)
	44.	Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group. [electronic resource] by Kok, T C van der Gaast, A Splinter, T A Tilanus, H W Producer: 19920109 In: European journal of cancer (Oxford, England : 1990) vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	45.	Evaluation of CA19-9 serum levels for monitoring disease activity during chemotherapy of pancreatic adenocarcinoma. [electronic resource] by Bac, D J Kok, T C van der Gaast, A Splinter, T A Producer: 19910621 In: Journal of cancer research and clinical oncology vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	46.	Sarcoid-like lymphadenopathy mimicking metastatic testicular cancer. [electronic resource] by Kok, T C Haasjes, J G Splinter, T A ten Kate, F J Producer: 19911029 In: Cancer vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	47.	Tubuloreticular structures in human lymphoid cell lines. A cell biological study. [electronic resource] by Splinter, T A Helder, A W Lucas, C J Feltkamp-Vroom, T M Producer: 19760320 In: British journal of experimental pathology vol. 56 Availability: No items available. Save to lists Add to cart (remove)
	48.	Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract. [electronic resource] by van der Gaast, A Kirkels, W J Blijenberg, B G Splinter, T A Producer: 19921008 In: Journal of cancer research and clinical oncology vol. 118 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	49.	Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma. [electronic resource] by van der Gaast, A Hoekstra, J W Croles, J J Splinter, T A Producer: 19910425 In: The Journal of urology vol. 145 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	50.	Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response. [electronic resource] by Splinter, T A Denis, L Scher, H I Schröder, F H Dalesio, O Producer: 19891023 In: Progress in clinical and biological research vol. 303 Availability: No items available. Save to lists Add to cart (remove)
	51.	Acute myeloid leukaemia with +i(12p) shortly after treatment of mediastinal germ cell tumour. [electronic resource] by Vlasveld, L T Splinter, T A Hagemeijer, A Van Lom, K Löwenberg, B Producer: 19950130 In: British journal of haematology vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	52.	Neuron-specific enolase as a guide to the treatment of small cell lung cancer. [electronic resource] by Splinter, T A Cooper, E H Kho, G S Oosterom, R Peake, M D Producer: 19880502 In: European journal of cancer & clinical oncology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	53.	Decarboxylated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxylase inhibition by alpha-difluoromethylornithine. [electronic resource] by Haegele, K D Splinter, T A Romijn, J C Schechter, P J Sjoerdsma, A Producer: 19870304 In: Cancer research vol. 47 Availability: No items available. Save to lists Add to cart (remove)
	54.	Capping of surface immunoglobulin on 'hairy cells' is independent of energy production. [electronic resource] by Splinter, T A Collard, J G De Wildt, A Temmink, J H Décary, F Producer: 19790925 In: Journal of cell science vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	55.	A phase I dose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer. [electronic resource] by van der Gaast, A Kok, T C Vos, R Kerkhofs, L Splinter, T A Producer: 19980128 In: Seminars in oncology vol. 24 Availability: No items available. Save to lists Add to cart (remove)
	56.	New prognostic factors in resectable non-small cell lung cancer. [electronic resource] by Smit, E F Groen, H J Splinter, T A Ebels, T Postmus, P E Producer: 19960829 In: Thorax vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	57.	The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer. [electronic resource] by Giaccone, G Splinter, T A Kirkpatrick, A Dalesio, O van Zandwijk, N McVie, J G Producer: 19921026 In: Seminars in oncology vol. 19 Availability: No items available. Save to lists Add to cart (remove)
	58.	Correlation between changes in the tumour markers CA-M26 and CA-M29 and standard response evaluation in patients with metastatic breast cancer. [electronic resource] by van der Gaast, A Hulshof, C Kok, T C van Loon, E Splinter, T A Producer: 19930607 In: European journal of cancer (Oxford, England : 1990) vol. 29A Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	59.	Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. [electronic resource] by van der Gaast, A Kok, T C van der Linden, N H Splinter, T A Producer: 19900123 In: European journal of cancer & clinical oncology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	60.	Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer. [electronic resource] by van der Gaast, A Bontenbal, M Planting, A S Kok, T C Splinter, T A Producer: 19950316 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 122 results.